💰The Funding Letter #1359: February 23

Antora Energy, Abridge, EigenLayer, and more...

February 23, 2024

Happy Friday! This exclusive edition of The Funding Letter comes to you from our headquarters in New York City. Have a great weekend!

Hit the Gong 🎉

Source: @overheard_sales + @sales_bant_er

Daily Deals 💸

🌎 Americas

Ocular Therapeutix operates a biopharmaceutical company that focuses on developing and commercializing innovative therapies for eye diseases and conditions. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $325M, Post-IPO Equity

Round Investors: Perceptive Advisors, TCG Crossover, Opaleye Management, Great Point Partners

🚀Growth Focus: Accelerate the clinical development of AXPAXLI™ for the treatment of wet AMD; support its other clinical development programs.

HQ: Bedford, MA

Industry: Pharmaceutical Manufacturing

Employee Count: 259

Subscribe to TFL All-Access Tier to read the rest.

Become a paying subscriber of TFL All-Access Tier to get access to this post and other subscriber-only content.

Already a paying subscriber? Sign In.

A subscription gets you:

  • • Exclusive Access to The Funding Letter, delivering hundreds of leads to your inbox each month
  • • Searchable weekly, monthly, and annual datasets of funding announcement leads, so you can quickly find the most relevant data
  • • The hottest Sales Gigs in the industry, sourced from the fastest growing startups
  • • ..and much more to come!